Cypress Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Sell
29,337
-679
-2% -$54.8K 0.62% 38
2026
Q1
$2.6M Sell
30,016
-256
-0.8% -$24.5K 0.74% 30
2025
Q4
$2.91M Buy
30,272
+660
+2% +$64.1K 0.81% 22
2025
Q3
$2.82M Sell
29,612
-857
-3% -$78.8K 0.81% 22
2025
Q2
$2.66M Buy
30,469
+11,684
+62% +$991K 0.77% 24
2025
Q1
$1.69M Buy
+18,785
New +$1.68M 0.49% 40

Other funds holding MDT

Cypress Capital's MDT Position: Q2 2026 in Review

Cypress Capital reduced its Medtronic (MDT) stake by 2.3% in Q2 2026, selling an estimated $54.8K and leaving 29,337 shares worth $2.3M. The position accounts for 0.62% of the portfolio, ranked #38.

Cypress Capital first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.91M in Q4 2025. 425 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cypress Capital held 29,337 shares of Medtronic worth $2.3M as of Q2 2026.
  • Cypress Capital sold 679 Medtronic shares in Q2 2026, an estimated $54.8K.
  • Medtronic made up 0.62% of Cypress Capital's portfolio in Q2 2026, its #38 holding.
  • Cypress Capital first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Cypress Capital's Medtronic position peaked at $2.91M in Q4 2025.
  • 425 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.